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Renal function assessment is crucial in critically ill patients. Both acute kidney injury and augmented renal clearance (ARC) may
compromise outcome.
Common formulas to estimate glomerular filtration rate (GFR) are unreliable in critically ill adults (1).
Our aim was to evaluate the feasibility of measuring plasma iohexol clearance (CLIOHEX) for GFR assessment in critically ill
children and to compare CLIOHEX with estimated GFR using the modified Schwartz formula (eGFRSchwartz).
- prospective, interventional study
- injection of a weight-dependent bolus of iohexol (Omnipaque 300)
- CLIOHEX calculation using non-compartimental analysis with area under the curve based on 6 iohexol sampling points over a 6-
hours interval
. ARC was defined as a GFR exceeding normal values for age plus two standard deviations.
CLIOHEX was safely used to assess true GFR in critically ill children. There was a relatively good correlation between CLIOHEX and
eGFRSchwartz , however, eGFRSchwartz systematically underestimates true GFR, especially in patients with ARC, and seems not reliable in
this patients population.
TABLE: PATIENT CHARACTERISTICS                   
Pearson’s correlation coefficient r = 0,64   p < 0,01
ULOA = upper limit of agreement; LLOA = lower limit of agreement
Bias = mean difference between CLIOHEX and eGFRSchwartz
ICU, intensive care unit; PRISM II , pediatric risk of mortality score score
a on day 1 of PICU admission, b on day of iohexol clearance 
Number (%) or 
median (IQR)
Male 29 (73)
Female 11 (27)
Age, months 16 (5-43)
Weight, kg 10 (7-13)
PRISM II Score 7 (0 -12
Primary reason for ICU admission
Postoperative
Neurologic disorder
Respiratory disorder
Cardiovascular disorder
Burns
Hematologic/oncologic disorder
Trauma
Sepsis 
)                                                                     
15 (38)
3 (8)             
11 (28)                                                                           
2 (5)                                                                                
1 (3)                    
1 (3)                                                                             
5 (13)                                                                          
2 (5)                                 
PICU mortality 3 (8)
Serum creatinine day 1
a
, mg/dL 0.5 (0.38-
0,52)
Serum creatinineb , mg/dL 0.42 (0.34-0.49)
eGFRSchwartzb, ml/min/1.73m
2, (range ) 83 (31-131)
CLIOHEX, ml/min/1.73m
2, (range) 121 ( 43-221)
ARCb based on CL IOHEX 20(50)
ARCb based on eGFR Schwartz 1(3)
CONCLUSIONS
